ResMed Inc. (RMD) Announces Quarterly Dividend of $0.25
ResMed (NYSE:RMD) announced a quarterly dividend on Friday, October 25th, Analyst Ratings News reports. Stockholders of record on Tuesday, November 19th will be paid a dividend of $0.25 per share on Wednesday, December 18th. This represents a $1.00 annualized dividend and a dividend yield of 2.02%. The ex-dividend date is Friday, November 15th.
A number of analysts have recently weighed in on RMD shares. Analysts at UBS AG upgraded shares of ResMed from a “neutral” rating to a “buy” rating in a research note to investors on Friday. On a related note, analysts at Deutsche Bank downgraded shares of ResMed from a “buy” rating to a “hold” rating in a research note to investors on Friday. They now have a $54.00 price target on the stock, down previously from $58.00. Finally, analysts at Piper Jaffray Cos. raised their price target on shares of ResMed from $54.00 to $59.00 in a research note to investors on Wednesday, October 9th. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $48.93.
Shares of ResMed (NYSE:RMD) traded down 12.00% during mid-day trading on Friday, hitting $49.55. 6,832,270 shares of the company’s stock traded hands. ResMed has a one year low of $37.31 and a one year high of $52.77. The stock has a 50-day moving average of $48.96 and a 200-day moving average of $46.95. The company has a market cap of $7.039 billion and a P/E ratio of 26.81. ResMed also was the recipient of unusually large options trading on Friday. Traders bought 12,526 put options on the company. This is an increase of 433% compared to the typical volume of 2,352 put options.
ResMed (NYSE:RMD) last released its earnings data on Thursday, October 24th. The company reported $0.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.02. The company had revenue of $357.66 million for the quarter, compared to the consensus estimate of $372.28 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis.
ResMed Inc, (NYSE:RMD) is a holding company for the ResMed Group.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.